Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Doris Soebbing

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
American Journal of Hematology|March 6, 2024
Results of a phase I trial with Haploidentical mbIL-21 ex vivo expanded NK cells for patients with multiply relapsed and refractory AMLStefan O Ciurea, Piyanuch Kongtim, Samer Srour, et al.
Blood|August 25, 2017
Phase 1 clinical trial using mbIL21 ex vivo-expanded donor-derived NK cells after haploidentical transplantationStefan O Ciurea, Jolie R Schafer, Roland Bassett, et al.
Bone Marrow Transplantation|October 20, 2018
Pilot study using post-transplant cyclophosphamide (PTCy), tacrolimus and mycophenolate GVHD prophylaxis for older patients receiving 10/10 HLA-matched unrelated donor hematopoietic stem cell transplantationMithun Vinod Shah, Rima M Saliba, Gabriela Rondon, et al.
Leukemia|July 27, 2021
Decrease post-transplant relapse using donor-derived expanded NK-cellsStefan O Ciurea, Piyanuch Kongtim, Doris Soebbing, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
American Journal of Hematology|March 6, 2024
Results of a phase I trial with Haploidentical mbIL-21 ex vivo expanded NK cells for patients with multiply relapsed and refractory AMLStefan O Ciurea, Piyanuch Kongtim, Samer Srour, et al.
Blood|August 25, 2017
Phase 1 clinical trial using mbIL21 ex vivo-expanded donor-derived NK cells after haploidentical transplantationStefan O Ciurea, Jolie R Schafer, Roland Bassett, et al.
Bone Marrow Transplantation|October 20, 2018
Pilot study using post-transplant cyclophosphamide (PTCy), tacrolimus and mycophenolate GVHD prophylaxis for older patients receiving 10/10 HLA-matched unrelated donor hematopoietic stem cell transplantationMithun Vinod Shah, Rima M Saliba, Gabriela Rondon, et al.
Leukemia|July 27, 2021
Decrease post-transplant relapse using donor-derived expanded NK-cellsStefan O Ciurea, Piyanuch Kongtim, Doris Soebbing, et al.
Pageof 1